Abstract:Biniam Endale Geleta, Girma Seyoum Department of Anatomy, Addis Ababa University, Addis Ababa, Ethiopia Correspondence: Biniam Endale Geleta, Email Background: Children with DS are at higher risk of developing congenital anomalies, particularly cardiac anomalies. Methods: Medical records of 502 DS patients were reviewed. The logistic regression analyses were performed to determine independent predictors. Results: Of the total 502 study subjects, 53.4% were males. Only 1.4% of the DS case diagnosis were confirmed by karyotyping. All cases were diagnosed postnatally. The median age at DS diagnosis was 5 months. About 13% were born preterm; 50.2% of the subjects maternal age at conception were thirty-five years and above. Over three-quarters (75.1%) had at least one structural congenital anomaly. Multiple anomalies were diagnosed in 12.8% of the subjects. At least one cardiac congenital anomaly was diagnosed in 67.3% of the study subjects, and 32.8% of them were diagnosed with multiple cardiac anomalies. Patent ductus arteriosus (28.5%), Ventricular septal defect (23.2%), and AVSD (21.9%) were the three common lesions. At least one genitourinary system anomaly was identified in 32 (6.4%) of them. Roughly, 8% of study participants exhibited congenital anomaly of the head, eye, nose, and throat. Anorectal malformation was found as the most common gastrointestinal anomaly. Maternal age at conception was found as independent predictor for presence of structural congenital anomaly (AOR 2.59; 95% CI 1.58– 4.23, p-value < 0.01). Advanced maternal age is also found increasing the risk of developing congenital heart defect (AOR 2.37; 95% CI 1.52– 3.7, p-value < 0.01). Conclusion: High prevalence of congenital anomalies has been noted in the current study compared to previous studies. Predictive factors increasing risk of congenital anomalies in DS patients have been identified. The current findings may help in developing strategies and more targeted preventive and therapeutic interventions. Keywords: Down syndrome, congenital anomaly, cardiac anomaly, maternal age, chromosome 21 Down syndrome (DS) is a chromosomal abnormality characterized by the presence of an extra copy of human chromosome 21. 1 It is the most prevalent chromosomal abnormality that allows for survival beyond the embryonic stage; affecting 1 per 700 to 1000 live births globally. 2–4 The incidence of Down syndrome (DS) is decreasing in developed countries due to widespread prenatal testing and elective termination of affected pregnancies. 5 In contrast, limited access to antenatal care in Africa and other developing countries poses a significant challenge for prenatal DS diagnosis, leading to late diagnoses after birth. 1,6 While karyotyping remains the gold standard for DS diagnosis, its accessibility and affordability are significant barriers in developing countries like Ethiopia. Therefore, clinical diagnosis based on physical features and behavior is commonly employed in these settings, including the one in which this study was conducted. 6–8 However, these clinical diagnostic standards were primarily developed in high-income countries and may not be as accurate in LMICs due to potential phenotypic variations across regions and ethnicities. 1,8,9 Additionally, studies have shown that the accuracy of clinical diagnosis varies significantly between DS subtypes. One study reported overdiagnosis in up to one-third of cases, while another found accuracy rates of 90% for free trisomy, 100% for translocation, and only 37.5% for mosaicism. 9,10 Congenital anomalies are more common among DS patients than the general population. This is attributed to a combination of gene dosage imbalance and epigenetic factors. However, the pattern and prevalence of these anomalies vary from one region to the other. 11 Stoll et al reported 64% prevalence of congenital anomalies in children with DS. While the Egyptian study reported 59.9% prevalence among infants. 12 Chance of development of these anomalies was found increased by factors like advanced maternal age, paternal age, gestational age, and birth weight. 13 Cardiac lesions are the most common congenital anomalies among children with DS. About half of patients with DS have at least one form of cardiac anomaly. 12,14 Variations are noted among regions. Accordingly, a study of twenty European countries reported prevalence of 43.6%. Other studies from Urban and rural areas of France and Guatemala reported 44% and 54%, respectively. 14,15 While the study from Sub-Saharan Sudan found 91% prevalence among clinically diagnosed children undergone echocardiographic examination. 16 Gender variation was note -Abstract Truncated-

Pathophysiology of obesity.

Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome

High mortality rate of preterm infants with Down syndrome

Prevalence, prenatal screening and neonatal features in children with Down syndrome: a registry-based national study

Death of children with Down syndrome by gestational age and cause

Prevalence and Patterns of Congenital Heart Defects and Other Major Non-Syndromic Congenital Anomalies Among Down Syndrome Patients: A Retrospective Study

Prevalence and Outcomes of Gastrointestinal Anomalies in Down Syndrome

Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study

Differences in Prenatal Diagnosis Rate of Congenital Anomalies Associated with Singletons and Multiple Births: an Observational Study of More Than 1.9 Million Births in Zhejiang Province, Eastern China, During 2012–2018

Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women

Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome

Explaining variation in Down's syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews

Explaining variation in Down’s syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews

Contemporary prenatal diagnosis of congenital heart disease in a regional perinatal center lacking onsite pediatric cardiac surgery: obstetrical and neonatal outcomes

Study on the Effect of B-Ultrasound NT Scan in Early Pregnancy Combined with Serum Screening in Early and Middle Pregnancy for Down Syndrome

Antenatal screening for Down's syndrome

Has the introduction of increased genetic prenatal testing affected rates of termination of pregnancy due to fetal abnormality?

Genetic disorders and their association with morbidity and mortality in early preterm small for gestational age infants

Significance of Mid-Pregnancy Down Syndrome Risk Screening in Predicting Adverse Maternal and Fetal Outcomes

Adverse pregnancy outcome in fetuses with early increased nuchal translucency: prospective cohort study

Prenatal diagnosis, pregnancy determination and follow up of sex chromosome aneuploidy screened by non‐invasive prenatal testing from 122 453 unselected singleton pregnancies: A retrospective analysis of 7‐year experience